Early obesity management strategies, including GLP-1 agents, and bariatric surgery have an important role in the multidisciplinary approach to improve both quality of life and prognosis for the patient and their family. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.